Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat in Adult Patients With Cystic Fibrosis Homozygous for the F508del Mutation
NCT02325362Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miglustat in cystic fibrosis (CF), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2015; status: completed.
02
Drugs
miglustat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02325362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325362.